Scientific Reports · 2022 · 22 citations · 36 references
MedicineNeurologyNeuroscienceExercise TestingPhysical ActivitySleep MedicineCardiopulmonary Exercise TestingExercise TrainingMetabolic Adaptation To ExerciseMetabolic Responses To ExerciseSleep-disordered BreathingSleep-related Breathing DisordersApnea-hypopnea Index ReductionCerebral Glucose UtilizationCerebral Metabolic RateCognitive Decline PreventionExercise Challenge TestingExercise Prescription Based On Aerobic CapacityObstructive Sleep Apnea TherapySupervised Exercise Training
Abstract Impaired glucose metabolism reflects neuronal/synaptic dysfunction and cognitive function decline in patients with obstructive sleep apnea (OSA). The study investigated the extent to which exercise training (ET) improves cerebral metabolic glucose rate (CMRgl) and cognitive function in patients with OSA. Patients with moderate to severe OSA were randomly assigned to ET (3 times/week, n = 23) or no intervention (control, n = 24). Echocardiography and apolipoprotein ε4 (APOEε4) genotyping were obtained at baseline. Both groups underwent cardiopulmonary exercise testing, polysomnography, cognitive tests, brain magnetic resonance imaging, and 18 F-fluoro-2-deoxy- d -Glucose positron emission tomography ( 18 FDG-PET) at baseline and study end. Compared with control, exercise-trained group had improved exercise capacity, decreased apnea–hypopnea index (AHI), oxygen desaturation and arousal index; increased attention/executive functioning, increased CMRgl in the right frontal lobe ( P < 0.05). After ET an inverse relationships occurred between CMRgl and obstructive AHI (r = − 0.43, P < 0.05) and apnea arousal index (r = − 0.53, P < 0.05), and between the changes in CMRgl and changes in mean O 2 saturation during sleep and non-rapid eye movement sleep (r = − 0.43, P < 0.05), desaturation during arousal (r = − 0.44, P < 0.05), and time to attention function testing (r = − 0.46, P < 0.05). ET improves OSA severity and CMRg in the frontal lobe, which helps explain the improvement in attention/executive functioning. Our study provides promising data that reinforce the growing idea that ET may be a valuable tool to prevent hypoxia associated with decreased brain metabolism and cognitive functioning in patients with moderate to severe OSA. Trial registration: NCT02289625 (13/11/2014).
36
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
An Inventory for Measuring Depression
Aaron T. Beck · Archives of General Psychiatry · 1961 · 38.2K citations
Older Adults' Reasons for Using Technology while Aging in Place
Sebastiaan Theodorus Michaël Peek, Katrien Luijkx, M. D. Rijnaard et al. · Gerontology · 2015 · 19.7K citations · Full text